drugset / Trial / NCT01969201

FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST)

NCT01969201

Phase 4 Completed 710 enrolled IBSA Institut Biochimique SA
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of the non-inferiority study is to evaluate the clinical efficacy and the safety of two different subcutaneous FSH preparations (Fostimon versus Gonal-F) for controlled ovarian hyperstimulation in a GnRH-antagonist cycle.

Timeline

Start
2014-01
Primary completion
2016-06
Completion
2017-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Bravelle Unknown 75 iu Subcutaneous
Comparator Gonal-f Protein / enzyme biologic 75 iu Subcutaneous

Indications